Study met both co-primary endpoints with robust immune responses COVAXIN™ was found to be well-tolerated…
MARTINSRIED, Germany and MUNICH, Germany, Jan. 09, 2023 (GLOBE NEWSWIRE) — Proteros biostructures GmbH, a…
Internet City, Dubai–(Newsfile Corp. – January 9, 2023) – LBank Exchange, a global digital asset…
Brooklyn, New York–(Newsfile Corp. – January 9, 2023) – Bruder Office Furniture is pleased to…
Internet City, Dubai–(Newsfile Corp. – January 9, 2023) – LBank Exchange, a global digital asset…
The Medical Director of Medicaid Cancer Foundation H.E Dr. Zainab Shinkafi Bagudu has expressed her…
HONG KONG, Jan 9, 2023 – (ACN Newswire) – As the first round of Hong…
Bloom and Telam to team on distributed power and electrolyzer deployment opportunities, supporting the electrification…
BOSTON–(BUSINESS WIRE)–Privacy Wizards, a website dedicated to online privacy and cyber security, has published their…
— Certification expands Viralgen’s capacity threefold and positions the company as a world-leading CDMO —…
Viralgen receives cGMP certification to produce rAAV commercial grade product at new facility in San…
WALTHAM, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced…
PRESS RELEASE STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment…
First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases…
Financing to advance the scientific development of innovative COVID-19 nanobody treatments focused on protecting high-risk…
Press Release Nicox Announces Proposed Move to Euronext Growth Paris Intention to transfer listing…
Ad hoc announcement pursuant to Art. 53 LR Inhaled murepavadin shown to be well tolerated…
Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, January 09, 2023 Basilea Pharmaceutica…
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, and Rockville, MD, USA, January 9,…
Reported $402 million in preliminary* full-year 2022 global net VYVGART sales ADHERE topline results now…